Omeros Corporation (OMER)

Omeros Corporation (OMER) is a healthcare company (biotechnology) based in the United States. The share price is $13.92, down 16.55% on the day, which values the company at $1.01B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$13.92−16.55% today
Market value
$1.01B
P/E ratio
16.8×last 12 months
Forward P/E
6.4×
200-week average
$7.1196% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Omeros Corporation in more detail

OMER trades at 16.8× its last twelve months' earnings, 6.4× next year's expected earnings, 13.6× sales. It sits 96% above its 200-week average of $7.11.

Worth checking: Weak Piotroski score.

Omeros Corporation (OMER): questions and answers

What is OMER's P/E ratio?

Omeros Corporation trades at 16.8× its last twelve months' earnings and 6.4× next year's expected earnings.

What is OMER's PEG ratio?

Omeros Corporation's PEG ratio is 0.81 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Omeros Corporation's market cap?

Omeros Corporation is valued at $1.01B at a share price of $13.92.

Is OMER above its 200-week moving average?

Yes. OMER is 95.7% above its 200-week average of $7.11. Long-term investors watch that line because strong companies rarely trade below it for long.

Does OMER pay a dividend?

Omeros Corporation does not currently pay a regular dividend.

Cite this page

Funkfolio, “Omeros Corporation (OMER) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/OMER

Underlying data: Yahoo Finance; company filings with the SEC.